Neuronetics, Inc.

Healthcare · Medical Devices · United States

Last price 2.25 USD (Oct 30, 2026, 4:00 PM EDT) · Market cap 171.44M

Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports

Neuronetics, Inc. engages in providing in office treatments for patients with neurohealth disorders in the United States and internationally. The company provides NeuroStar Advanced Therapy System, a non-invasive and non-systemic office-based treatment to treat adult patients with major depressive disorder. Its NeuroStar Advanced Therapy System uses transcranial magnetic stimulation to create a pulsed, MRI-strength magnetic field that induces electrical currents designed to stimulate specific areas of the brain associated with mood. The company...